|
|
||||||||
and TNF-
, and the Noninvolvement of IL-6, in the Development of Monoclonal Antibody-Induced Arthritis
Biological Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan
Injection of anti-type II collagen Ab and LPS induces arthritis
in mice. The levels of IL-1
, IL-6, and chemokines (macrophage
inflammatory protein (MIP)-1
, MIP-2, and monocyte chemoattractant
protein-1) in the hind paws increased with the onset of arthritis and
correlated highly with arthritis scores. The level of TNF-
was also
elevated, but only transiently. Quantitative real-time PCR analysis
revealed increases in cytokine and chemokine mRNA. To elucidate the
contribution of inflammatory cytokines and chemokines in arthritis
development more directly, recombinant proteins, neutralizing Abs, and
knockout mice were used. The injection of rIL-1
or TNF-
, but not
IL-6 or chemokines, induced arthritis when mice were i.v. preinjected
with anti-type II collagen Ab. However, a single injection of
recombinant cytokines or chemokines into the hind paws did not induce
swelling. Arthritis development was inhibited by neutralizing Ab
against IL-1
, TNF-
, or MIP-1
. In contrast, the inhibitory
effect by anti-MIP-2 Ab was partial and, surprisingly, Abs to IL-6
and monocyte chemoattractant protein-1 showed no inhibitory effect.
Furthermore, arthritis development in IL-1R-/- mice and
TNFR-/- mice was not observed at all, but severe
arthritis was developed in IL-6-/- mice. These results
suggest that IL-1
and TNF-
play more crucial roles than IL-6 or
chemokines in this model. Because arthritis was also developed in SCID
mice, the development of arthritis in the Ab-induced mice model is due
to a mechanism that does not involve T or B
cells.
This article has been cited by other articles:
![]() |
M. Kanayama, D. Kurotaki, J. Morimoto, T. Asano, Y. Matsui, Y. Nakayama, Y. Saito, K. Ito, C. Kimura, N. Iwasaki, et al. {alpha}9 Integrin and Its Ligands Constitute Critical Joint Microenvironments for Development of Autoimmune Arthritis J. Immunol., June 15, 2009; 182(12): 8015 - 8025. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Miller, Y. Ma, J. Bian, K. C. F. Sheehan, J. F. Zachary, J. H. Weis, R. D. Schreiber, and J. J. Weis A Critical Role for Type I IFN in Arthritis Development following Borrelia burgdorferi Infection of Mice J. Immunol., December 15, 2008; 181(12): 8492 - 8503. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. O'Keefe, J. S. Mudgett, S. Cupo, J. N. Parsons, N. A. Chartrain, C. Fitzgerald, S.-L. Chen, K. Lowitz, C. Rasa, D. Visco, et al. Chemical Genetics Define the Roles of p38{alpha} and p38 in Acute and Chronic Inflammation J. Biol. Chem., November 30, 2007; 282(48): 34663 - 34671. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zalevsky, T. Secher, S. A. Ezhevsky, L. Janot, P. M. Steed, C. O'Brien, A. Eivazi, J. Kung, D.-H. T. Nguyen, S. K. Doberstein, et al. Dominant-Negative Inhibitors of Soluble TNF Attenuate Experimental Arthritis without Suppressing Innate Immunity to Infection J. Immunol., August 1, 2007; 179(3): 1872 - 1883. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Butz, G. Li, S. M. Huebner, and M. E. Cook A mechanistic approach to understanding conjugated linoleic acid's role in inflammation using murine models of rheumatoid arthritis Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R669 - R676. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yanaba, Y. Hamaguchi, G. M. Venturi, D. A. Steeber, E. W. St. Clair, and T. F. Tedder B Cell Depletion Delays Collagen-Induced Arthritis in Mice: Arthritis Induction Requires Synergy between Humoral and Cell-Mediated Immunity J. Immunol., July 15, 2007; 179(2): 1369 - 1380. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Katschke Jr., K. Y. Helmy, M. Steffek, H. Xi, J. Yin, W. P. Lee, P. Gribling, K. H. Barck, R. A.D. Carano, R. E. Taylor, et al. A novel inhibitor of the alternative pathway of complement reverses inflammation and bone destruction in experimental arthritis J. Exp. Med., June 11, 2007; 204(6): 1319 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Shiau, S.-Y. Chen, M.-Y. Chang, C.-H. Su, S.-Y. Chung, Y.-T. Yo, C.-R. Wang, and C.-L. Wu Prothymosin {alpha} Lacking the Nuclear Localization Signal as an Effective Gene Therapeutic Strategy in Collagen-Induced Arthritis J. Immunol., April 1, 2007; 178(7): 4688 - 4694. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yarilina, E. DiCarlo, and L. B. Ivashkiv Suppression of the Effector Phase of Inflammatory Arthritis by Double-Stranded RNA Is Mediated by Type I IFNs J. Immunol., February 15, 2007; 178(4): 2204 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Fusello, L. Mandik-Nayak, F. Shih, R. E. Lewis, P. M. Allen, and A. S. Shaw The MAPK Scaffold Kinase Suppressor of Ras Is Involved in ERK Activation by Stress and Proinflammatory Cytokines and Induction of Arthritis J. Immunol., November 1, 2006; 177(9): 6152 - 6158. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Honda, E. Segi-Nishida, Y. Miyachi, and S. Narumiya Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis J. Exp. Med., February 21, 2006; 203(2): 325 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yoshifuji, H. Umehara, H. Maruyama, M. Itoh, M. Tanaka, D. Kawabata, T. Fujii, and T. Mimori Amelioration of experimental arthritis by a calpain-inhibitory compound: regulation of cytokine production by E-64-d in vivo and in vitro Int. Immunol., October 1, 2005; 17(10): 1327 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Burns, M. Abadi, and L.-a. Pirofski Modulation of the Lung Inflammatory Response to Serotype 8 Pneumococcal Infection by a Human Immunoglobulin M Monoclonal Antibody to Serotype 8 Capsular Polysaccharide Infect. Immun., August 1, 2005; 73(8): 4530 - 4538. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-K. Lee, S.-M. Kang, D.-J. Paik, J. M. Kim, and J. Youn Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS Int. Immunol., March 1, 2005; 17(3): 325 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, M. Kohli, Q. Zhou, D. T. Graves, and S. Amar Short- and Long-Term Effects of IL-1 and TNF Antagonists on Periodontal Wound Healing J. Immunol., September 1, 2004; 173(5): 3514 - 3523. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Wipke, Z. Wang, W. Nagengast, D. E. Reichert, and P. M. Allen Staging the Initiation of Autoantibody-Induced Arthritis: A Critical Role for Immune Complexes J. Immunol., June 15, 2004; 172(12): 7694 - 7702. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Nandakumar, L. Svensson, and R. Holmdahl Collagen Type II-Specific Monoclonal Antibody-Induced Arthritis in Mice: Description of the Disease and the Influence of Age, Sex, and Genes Am. J. Pathol., November 1, 2003; 163(5): 1827 - 1837. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Murata, M. Inami, A. Hasegawa, S. Kubo, M. Kimura, M. Yamashita, H. Hosokawa, T. Nagao, K. Suzuki, K. Hashimoto, et al. CD69-null mice protected from arthritis induced with anti-type II collagen antibodies Int. Immunol., August 1, 2003; 15(8): 987 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Brown, V. A. Blaho, and C. M. Loiacono Susceptibility to Experimental Lyme Arthritis Correlates with KC and Monocyte Chemoattractant Protein-1 Production in Joints and Requires Neutrophil Recruitment Via CXCR2 J. Immunol., July 15, 2003; 171(2): 893 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fairweather, S. Yusung, S. Frisancho, M. Barrett, S. Gatewood, R. Steele, and N. R. Rose IL-12 Receptor {beta}1 and Toll-Like Receptor 4 Increase IL-1{beta}- and IL-18-Associated Myocarditis and Coxsackievirus Replication J. Immunol., May 1, 2003; 170(9): 4731 - 4737. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kagari, D. Tanaka, H. Doi, and T. Shimozato Essential Role of Fc{gamma} Receptors in Anti-Type II Collagen Antibody-Induced Arthritis J. Immunol., April 15, 2003; 170(8): 4318 - 4324. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Choe, B. Crain, S. R. Wu, and M. Corr Interleukin 1 Receptor Dependence of Serum Transferred Arthritis Can be Circumvented by Toll-like Receptor 4 Signaling J. Exp. Med., February 17, 2003; 197(4): 537 - 542. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |